
Salaires et Rémunération chez Trevi Therapeutics
Biotechnology Research
Trevi Therapeutics is a profoundly innovative, fiercely dedicated clinical-stage biopharmaceutical company absolutely pioneering highly advanced neurology treatments. They brilliantly develop incredibly targeted therapies—including their absolute breakthrough oral nalbuphine extended-release (Haduvio)—fiercely aiming to completely eradicate incredibly severe chronic cough and debilitating pruritus, profoundly transforming deeply critical patient quality of life.
Siège social:New Haven, United States
Fondée en:2011
Employés:1-50
Type:public
Revenu estimé:$0-$1M
Siège social
Pas encore de données salariales pour Trevi Therapeutics.
Soyez le premier à soumettre